No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an international supplier of bio-materials and surgical support services. The company specializes in breeding and producing Specific Pathogen-Free (SPF) laboratory rodents, encompassing various outbreed stocks, inbreed strains, and immune-deficient models, alongside providing bespoke animal model services. Its product portfolio extends to critical diagnostic and research tools, including kits for endotoxin detection, animal health diagnostics, and serological analysis, as well as biological indicators. Furthermore, BioLASCO furnishes a comprehensive array of laboratory equipment vital for animal research and facility management. This sophisticated equipment includes Individually Ventilated Cage (IVC) systems and ventilated housing units, professional automated animal watering systems, transponders, chlorine dioxide gas generators, and specialized devices such as mouse and rat tail cuff blood pressure systems, analgesia equipment, animal behavioral systems, metabolism and behavior tracking systems. The company also offers XPERT cabinet X-ray systems, automatic cleaning equipment, laboratory workstations, isolation chambers, and foggers.
www.biolasco.com.twNo one on the platform currently holds 6662.TWO.
No tracked institution reports a position in 6662.TWO as of their last filing.
No one on the platform has traded 6662.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 6662.TWOBioLASCO Taiwan Co., Ltd. | $28.40 | -0.35% | $727M | — |
| 3118.TWOLevel Biotechnology Inc. | $31.65 | +0.80% | $1.0B | — |
| 4192.TWOSynCore Biotechnology Co.,Ltd | $18.15 | -6.68% | $638M | — |
| 4732.TWONatureWise Biotech & Medicals Corporation | $18.00 | +0.00% | $869M | — |
| 6518.TWOConcord Medical Co., Ltd. | $32.60 | +0.62% | $1.1B | — |
| 6549.TWOTaiwanJ Pharmaceuticals Co., Ltd. | $6.83 | -1.44% | $547M | — |
| 6652.TWOEusol Biotech Co.,Ltd. | $1.96 | +0.00% | $269M | — |
Source: Financial Modeling Prep · peers by sector/industry